EDITOR'S NOTE
A paradigm shift in oncology nursing
Neil Love, MD

EDITOR Neil Love, MD FACULTY Paul A Bunn Jr, MD Karen Kelly, MD Susie Lehnerz, BA Lyn Magree, BS, CCRP Tina Russell, RN, OCN Karen J Stanley, RN, MSN, AOCN, FAAN

FACULTY INTERVIEWS
Patient Case Summaries

• Mr T: A 57-year-old very fit and active nonsmoker with recurrent
  non-small cell lung cancer (NSCLC)
• Mrs F: A 60-year-old flight attendant with compression of the superior vena cava secondary to small cell lung cancer
• Mr L: A 59-year-old man with small cell lung cancer

Excerpts from the Audio Program

• Clinical presentation of lung cancer
• Diagnosing and staging lung cancer
• Clinical management of patients with Stage I and II NSCLC
• Clinical management of patients with Stage III NSCLC
• First-line therapy for elderly patients or patients with comorbidities
• Clinical management of patients with Stage IV NSCLC
• Administration and side effects of gefitinib
• Rapidity and duration of response with gefitinib
• Gefitinib efficacy in specific patient subsets
• Symptom improvement with gefitinib
• Nurses’ role in the management of lung cancer
• Counseling patients about participation in randomized clinical trials
• Stigma associated with lung cancer
• Tailoring communications to individual patients
• Applying the biopsychosocial model to patients with lung cancer
• Psychological well-being
• Social well-being in the older patient with newly diagnosed lung cancer
• Spiritual well-being

Editor's Office

Continuing Education (CE) Information

Faculty Disclosures